基于MRI的深度学习模型预测肝内胆管癌Ki-67表达水平
该回顾性研究纳入117例肝内胆管癌患者,以免疫组化为参考标准分为Ki-67高表达组(>50%)和低表达组(≤50%),构建融合增强MRI与临床数据的深度学习模型。融合模型5折交叉验证平均AUC达84.24±8.82%,准确率87.17±5.95%,特异度93.07±9.35%,敏感度70.00±19.44%,显著优于单独临床或单独MRI模型。
要点
- 融合增强MRI与临床数据的深度学习模型可术前无创预测iCCA的Ki-67表达水平。
- 融合模型平均AUC为84.24±8.82%,特异度高达93.07±9.35%,但敏感度仅70.00±19.44%。
- 仅用临床变量的模型预测效能有限,平均AUC为53.18±14.60%。
局限性
- 单中心回顾性研究,样本量较小(共117例,高表达组仅30例)。
- 高、低表达组样本量不均衡。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Ki-67 expression is a valuable prognostic indicator in intrahepatic cholangiocarcinoma (iCCA). This study aimed to develop a non-invasive Deep learning (DL) model based on magnetic resonance imaging (MRI) and clinical data to predict Ki-67 expression preoperatively.
METHODS: Patients with iCCA between January 2020 and January 2024 were retrospectively reviewed. Based on immunohistochemistry, patients were classified into high-expression group (Ki-67 > 50%) and low-expression group (Ki-67 ≤ 50%). After image acquisition, tumor segmentation, and preprocessing, a 3D-ResNet10 network was utilized for MRI feature extraction. A feed-forward neural network (FFN) was used for clinical feature extraction. Subsequently, the extracted image and clinical features were fused and fed into a lightweight classifier to perform Ki-67 level prediction. The performance of the DL models was evaluated via 5-fold cross-validation using accuracy, precision, sensitivity, specificity, F1-score, and the area under the curve (AUC).
RESULTS: A total of 117 patients were ultimately included (30 cases in the high-expression group and 87 cases in the low-expression group). The model based solely on clinical variables demonstrated limited predictive efficacy (mean AUC: 53.18 ± 14.60%). The model utilizing MRI features alone exhibited high specificity (86.14 ± 10.25%) but modest sensitivity. In contrast, the fused DL model significantly outperformed both individual models, attaining a mean AUC of 84.24 ± 8.82%, an accuracy of 87.17 ± 5.95%, a specificity of 93.07 ± 9.35%, and a markedly improved sensitivity of 70.00 ± 19.44%, yielding a robust F1-score of 73.42 ± 12.28%.
CONCLUSIONS: We developed and validated a non-invasive DL model integrating contrast-enhanced MRI and clinical parameters that accurately predicts Ki-67 expression in iCCA, demonstrating superior diagnostic performance.
引用
- Wang C, Jin M, Zhang Y, et al. MRI-based deep learning model for prediction of Ki-67 expression level in intrahepatic cholangiocarcinoma. Abdom Radiol (NY). 2026. PMID: 42965590. doi:10.1007/s00261-026-05844-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。